CAI ▲ +1.2% - Caris Life Sciences, Inc.
$CAI CAI - Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
Caris Life Sciences rose 1.2% following an announcement that the company will present new precision oncology research at the IASLC 2026 World Conference on Lung Cancer, a major industry forum for lung cancer treatment advances. The presentation opportunity signals continued progress in the company's oncology work and upcoming visibility at a key medical conference.
02-SEP-2026 08:32 AM ET
Share this post
More filings for $CAI
CAI ▼ -1.1% - Caris Life Sciences, Inc.Sep 8, 2026CAI ▼ -0.9% - Caris Life Sciences, Inc.Aug 27, 2026CAI - Caris Life Sciences, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026CAI - Caris Life Sciences, Inc. - SEC Filing Update (07-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 7, 2026
View full $CAI filing history →💬 Comments
Loading comments…
Leave a comment
